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Abstract
The presence of P2X7 on erythroid cells is well established, but its physiological role remains
unclear. The current study aimed to determine if P2X7 activation induces reactive oxygen
species (ROS) formation in murine erythroleukaemia (MEL) cells, a commonly used
erythroid cell line. ATP induced ROS formation in a time- and concentration-dependent
fashion. The most potent P2X7 agonist, 2'(3')-O-(4-benzoylbenzoyl)ATP, but not UTP or
ADP, also induced ROS formation. The P2X7 antagonist, A-438079, impaired ATP-induced
ROS formation. The ROS scavenger, N-acetyl-L-cysteine, and the ROS inhibitor,
diphenyleneiodonium,

also

impaired

P2X7-induced

ROS

formation,

but

use

of

enzyme-specific ROS inhibitors failed to identify the intracellular source of P2X7-induced
ROS formation. P2X7-induced ROS formation was impaired partly by physiological
concentrations of Ca2+ and Mg2+, and almost completely in cells in N-methyl-D-glucamine
chloride medium. The p38 MAPK inhibitors SB202190 and SB203580, and the caspase
inhibitor Z-VAD-FMK, but not N-acetyl-L-cysteine, impaired P2X7-induced MEL cell
apoptosis. ATP also stimulated p38 MAPK and caspase activation, both of which could be
impaired by A-438079. In conclusion, these findings indicate that P2X7 activation induces
ROS formation in MEL cells and that this process may be involved in events downstream of
P2X7 activation, other than apoptosis, in erythroid cells.

Keywords: P2X7; extracellular ATP; red blood cell; reactive oxygen species; apoptosis
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Introduction

The P2X7 receptor is a trimeric ATP-gated cation channel that mediates the influx of
extracellular Ca2+ and Na+, and efflux of intracellular K+, as well as the uptake of organic
cations including N-methyl-D-glucamine+ (NMDG+) and fluorescent dyes such as ethidium+
[1]. P2X7 is expressed on haematopoietic, epithelial, bone and neuronal cells, where it
functions in inflammation and immunity [2], and cellular homeostasis [3]. Due to these and
other properties of P2X7 activation, this receptor plays important roles in health and disease
[4]. The various biological roles attributed to P2X7 are the result of various signalling events
downstream of P2X7 activation including reactive oxygen species (ROS) formation [5].
P2X7 activation induces ROS generation in a variety of cell types resulting in transcription
factor activation [6], pro-inflammatory cytokine release [7, 8], microbial killing [9], cell
death [10, 11] and autophagy [12]. However, it remains unknown if P2X7 activation can
induce ROS formation in erythroid cells.
The presence of P2X7 on erythroid cells is well established, but its physiological role
remains unclear. P2X7 is present on mature red blood cells (erythrocytes) [13, 14] where it
participates in cation fluxes [13, 15-17], cell death [16, 18-20]	
  and the release of lipid-derived
mediators [21]. P2X7 is also present on erythroid precursors including murine
erythroleukaemia (MEL) cells [22, 23]. Our group directly demonstrated that MEL cells
express P2X7, and that activation of this receptor induces the uptake of organic cations, rapid
phosphatidylserine exposure, microparticle release and apoptosis in these cells [23]. In the
current study, we demonstrate that P2X7 activation also induces ROS formation in MEL cells,
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supporting a potential role for P2X7-induced ROS formation in intracellular signalling or
oxidative stress in erythroid cells.

Material and methods

Reagents RPMI-1640 medium, L-glutamine, gentamicin and 2’,7’-dichlorodihydrofluorescein
diacetate (H2DCFDA) were from Invitrogen (Grand Island, NJ, USA). FCS (heat inactivated
before use) was from Lonza (Basel, Switzerland) or Bovogen Biologicals (East Kellior,
Australia).

ATP,

2'(3')-O-(4-benzoylbenzoyl)ATP

(BzATP),

ADP,

UTP,

rotenone,

allopurinol, Nω-nitro-L-arginine methyl ester hydrochloride (L-NAME), EGTA and
BAPTA-AM were from Sigma Chemical Co (St Louis, MO, USA). A-438079 was from
Tocris

Bioscience

(Ellisville,

MO,

USA).

N-acetyl-L-cysteine

(NAC)

and

7-aminoactinomycin D (7AAD) were from Alexis Biochemicals (Lausen, Switzerland).
Diphenyleneiodonium (DPI) was from Cayman Chemical Company (Ann Arbor, MI, USA).
Ethidium bromide was from Amresco (Solon, OH, USA). Apocynin and SB202190 were
from Calbiochem (San Diego, CA, USA). Annexin-V-FLUOS and DNase I were from Roche
Applied Science (Pensberg, Germany). SB203580 and Z-VAD-FMK were from Jena
Bioscience (Jena, Germany) and BioVision (Mountain View, CA, USA), respectively.

Cell culture MEL cells were maintained in complete culture medium (RPMI-1640 medium
containing 10% FCS, 2 mM L-glutamine and 5 ng/ml gentamicin) as described [23].
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ROS formation measurements ATP-induced ROS formation was assessed in MEL cells
loaded

with

H2DCFDA,

which

is

converted

to

the

fluorescent

compound

2',7'-dichlorofluorescein (DCF) upon oxidation by ROS. Briefly, MEL cells in NaCl medium
(145 mM NaCl, 5 mM KCl, 5 mM D-glucose, 10 mM HEPES, pH 7.4) (1×106 cells/ml) were
incubated with 5 µM H2DCFDA for 5 min at 37°C. Cells were centrifuged and washed once
with NaCl medium. H2DCFDA-loaded cells in NaCl medium were incubated in the absence
or presence of nucleotides (as indicated) at 37°C. Incubations were stopped by addition of an
equal volume of ice-cold MgCl2 medium (145 mM NaCl, 5 mM KCl, 20 mM MgCl2, 10 mM
HEPES, pH 7.4) and centrifugation. Cells were washed once with NaCl medium. The mean
fluorescence intensity (MFI) of DCF fluorescence (ROS formation) was determined using a
BD (San Diego, CA, USA) LSR II flow cytometer and FlowJo software (Tree Star, Ashland,
OR, USA).
In some experiments, ATP-induced ROS formation was assessed in cells pre-incubated
in the absence or presence of different compounds (as indicated) at 37°C before the addition
of ATP. In other experiments, ATP-induced ROS formation was assessed in cells in NaCl
medium containing 2 mM CaCl2 and 1 mM MgCl2, KCl medium (150 mM KCl, 5 mM
D-glucose,

10 mM HEPES, pH 7.4), N-methyl-D-glucamine chloride (NMDG Cl) medium

(145 mM NMDG Cl, 5 mM KCl, 5 mM D-glucose, 10 mM HEPES, pH 7.4), complete
culture medium, or in NaCl medium containing either 1 mM CaCl2, 100 µM EGTA or 1 mM
Mg2+. Since free Ca2+ or Mg2+ can lower the concentration of ATP4-, cells in the presence of
1 mM Ca2+ or 1 mM Mg2+ in some experiments were incubated with 1.54 or 1.74 mM ATP,
respectively to provide equimolar ATP4- concentrations (415 µM) as calculated using the
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Bound and Determined Program [24].

Ethidium+ uptake measurements P2X7-induced pore formation in MEL cells suspended in
NaCl medium was assessed using a fixed-time ethidium+ uptake assay as described [23]. The
MFI of ethidium+ uptake (pore formation) was determined by flow cytometry. In some
experiments, ATP-induced ethidium+ uptake was assessed in cells pre-incubated with
different compounds or incubated in different media as above (for ROS formation).

Apoptosis measurements P2X7-induced apoptosis of MEL cells was performed as described
[23]. Briefly, cells were pre-incubated in the absence or presence of different compounds (as
indicated) at 37°C, followed by incubation in the absence or presence of 1 mM ATP for 24 h.
Following ATP incubation, the percentage of Annexin-V+/7AAD− (early apoptotic) and
Annexin-V+/7AAD+ (late apoptotic) cells was determined by flow cytometry.

p38 MAPK activation measurements MEL cells in complete culture medium in 24-well plates
(5×105 cells/ml/well) were pre-incubated in the absence or presence of 10 µM A-438079 for
15 min at 37°C, followed by incubation in the absence or presence of 1 mM ATP for 5 min.
Harvested cells were suspended in 100 µL ice-cold SDS sample buffer containing 5%
2-mercaptoethanol, and sonicated in the presence of DNase I (10 µg/ml) for 5 min. Proteins
were separated by SDS-PAGE (4% stacking and 10% resolving gels) and transferred to
nitrocellulose membrane (Bio-Rad, Hercules, CA, USA). Immunoblotting of p38 MAPK and
phospho-p38 MAPK was performed using the PhosphoPlus p38 MAPK (Thr180/Tyr182)
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Antibody Kit (Cell Signaling Technology, Danvers, MA, USA) according to the
manufacturer’s instructions.

Caspase activation measurements Caspase activation was assessed using the CaspGLOW
Fluorescein Active Caspase Staining Kit (BioVision) according to the manufacturer’s
instructions. Briefly, MEL cells in complete culture medium in 24-well plates (5×105
cells/ml/well) were pre-incubated in the absence or presence of 10 µM A-438079 for 15 min
at 37°C, followed by incubation in the absence or presence of 1 mM ATP for 6 h. Following
ATP incubation, cells were incubated with fluorescein isothiocyanate (FITC)-VAD-FMK for
1 h at 37°C; 7AAD was added during the final 5 min of incubation. Cells were harvested and
washed twice with Wash Buffer. The percentage of FITC+/7AAD+ (caspase activated) cells
was determined by flow cytometry.

Presentation of data and statistical analysis Results are presented as means ± SD. Data was
compared using one-way analysis of variance (using Tukey's post test) or (when indicated)
the unpaired two-tailed Student’s t-test using Prism 5 (GraphPad Software, San Diego, CA,
USA) with P < 0.05 considered significant.

Results

P2X7 activation induces ROS formation in MEL cells To determine whether P2X7 activation
can induce ROS formation in MEL cells, cells were loaded with with H2DCFDA, which is
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converted to the fluorescent compound DCF upon oxidation by ROS. Cells in NaCl medium
(nominally free of Ca2+ and Mg2+) were then incubated in the absence or presence of ATP for
up to 30 mins, and the amount of ROS formation determined by flow cytometry. ATP
induced ROS formation in MEL cells in a time-dependent fashion (Fig. 1A). Moreover, ATP
induced ROS formation in a concentration-dependent fashion, with a maximal response at 2
mM ATP and an EC50 of 151 µM (95% confidence interval of 120-190 µM) (Fig. 1B). This is
similar to the EC50 for ATP-induced ethidium+ uptake in MEL cells [23] and for cation fluxes
mediated by recombinant murine P2X7 [25].
To determine further if the ATP-induced ROS formation in MEL cells was mediated by
P2X7 activation, cells were incubated in the absence or presence of the most potent P2X7
agonist BzATP, or the non-P2X7 agonists ADP or UTP [25]; although it should be noted that
BzATP also activates P2X1-P2X5 [26, 27]. ATP was included as a positive control. Both
ATP and BzATP induced significant ROS formation in MEL cells compared to cells
incubated in the absence of nucleotide (Fig. 1C). In contrast, ADP or UTP failed to induce
ROS formation (Fig. 1C). Finally, to confirm that ATP-induced ROS formation was mediated
by P2X7 activation, MEL cells were pre-incubated in the absence or presence of the P2X7
antagonist A-438079, before incubation in the absence or presence of ATP. As above (Fig.
1A-C), ATP induced significant ROS formation in MEL cells compared to cells incubated in
the absence of ATP (Fig. 1D). Pre-incubation of MEL cells with 10 µM A-438079 impaired
ATP-induced ROS formation by 87 ± 1% (Fig. 1D). Collectively, these results indicate that
extracellular ATP induces ROS formation in MEL cells by P2X7 activation.
The above studies were conducted with MEL cells suspended in NaCl medium
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nominally free of Ca2+ and Mg2+. Therefore, to assess if ATP could induce ROS formation in
MEL cells in medium containing physiological concentrations of divalent cations, MEL cells
were suspended in NaCl medium containing 2 mM Ca2+ and 1 mM Mg2+, and the
ATP-induced ROS formation was assessed. Due to the known inhibitory actions of Ca2+ and
Mg2+ on P2X7 [28, 29], cells were exposed to 1 mM ATP (as above), as well as 2 and 3 mM
ATP. ATP induced ROS formation in MEL cells in NaCl medium (containing physiological
concentrations of divalent cations) in a concentration-dependent fashion (Fig. 1E).

P2X7-induced ROS formation in MEL cells is impaired by NAC and DPI To confirm that
P2X7 activation induced ROS formation in MEL cells, cells in NaCl medium (nominally free
of Ca2+ and Mg2+) were pre-incubated in the absence or presence of the ROS scavenger NAC,
or in the presence of DMSO diluent control or the broad-spectrum ROS inhibitor DPI before
incubation in the absence or presence of ATP. As above (Fig. 1), ATP induced significant
ROS formation in MEL cells compared to cells incubated in the absence of ATP (Fig. 2A,B).
Pre-incubation of MEL cells with 10 mM NAC or 20 µM DPI impaired ATP-induced ROS
formation by 70 ± 7% and 50 ± 15%, respectively (Fig. 2A,B). To determine if NAC or DPI
directly affected P2X7, ATP-induced ethidium+ uptake was measured in the absence or
presence of each compound. Pre-incubation of MEL cells with NAC or DPI (as above) did
not alter the amount of ATP-induced ethidium+ uptake (Fig. 2A,B).
ROS can be generated from numerous sources within cells. Therefore, in an attempt to
identify the intracellular source of ROS generated downstream of P2X7 activation, MEL cells
in NaCl medium (nominally free of Ca2+ and Mg2+) were pre-incubated in the presence of
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diluent control (as indicated), or apocynin, rotenone, allopurinol or L-NAME, which impair
NADPH oxidase, mitochondrial complex I, xanthine oxidase or nitric oxide synthase,
respectively, before incubation in the absence or presence of ATP. Pre-incubation times and
antagonist concentrations were based on previous studies with murine macrophages [10, 11].
Again, ATP induced significant ROS formation in MEL cells compared to cells incubated in
the absence of ATP (Fig. 2C-F). Pre-incubation of MEL cells with either 100 µM apocynin, 5
µM rotenone, 100 µM allopurinol or 1 mM L-NAME had no significant effect on
ATP-induced ROS formation compared to cells incubated with both the respective diluent
control and ATP (Fig. 2C-F). In the absence of ATP, ROS formation in the presence of
apocynin, allopurinol or L-NAME was not significantly different to the respective diluent
control (Fig. 2C,E,F). In contrast, in the absence of ATP, rotenone induced significant ROS
formation compared to DMSO (Fig. 2D). Shorter (45 min) incubations with different
concentrations of rotenone in the absence of ATP also induced ROS formation in MEL cells
in concentration-dependent fashion, with significant ROS formation observed with a
minimum of 0.5 µM rotenone and with an EC50 of >2 µM (results not shown). While 30 min
pre-incubation of MEL cells with 0.1 µM rotenone potentiated ATP-induced ROS formation
compared to cells incubated with both DMSO and ATP (results not shown). Pre-incubation of
MEL cells with either apocynin, rotenone, allopurinol or L-NAME (as above) had no
significant effect on ATP-induced ethidium+ uptake compared to cells incubated with both
the respective diluent control and ATP (Fig. 2C-F).

P2X7-induced ROS formation is impaired in MEL cells in NaCl medium containing Ca2+ or

	
  

10	
  

	
  

Mg2+, or in NMDG Cl medium P2X7 is a trimeric ATP-gated cation channel [1], therefore a
series of experiments were undertaken to explore a possible role for divalent or monovalent
cations in P2X7-induced ROS formation. For each experiment, cells in different media were
compared to cells in NaCl medium (nominally free of Ca2+ and Mg2+). P2X7-induced ROS
formation is dependent on Ca2+ influx in rat, but not murine, submandibular gland cells [30,
31]. Therefore, to determine if P2X7-induced ROS formation in MEL cells is dependent on
Ca2+ influx, ATP-induced ROS formation was compared in cells in the absence or presence
of additional Ca2+. ATP induced significant ROS formation in MEL cells in either the
absence or presence of 1 mM Ca2+ compared to similarly treated cells incubated in the
absence of ATP (Fig. 3A). Of note, ATP-induced ROS formation was significantly lower in
the presence of Ca2+ compared to ATP-induced ROS formation in the absence of Ca2+ (Fig.
3A). This result paralleled observations with ATP-induced ethidium+ uptake, with
ATP-induced ethidium+ uptake significantly lower in the presence of Ca2+ compared to
ATP-induced ethidium+ uptake in the absence of Ca2+ (Fig. 3A).
NaCl medium may contain nominal amounts of Ca2+. Therefore, to further exclude a role
for Ca2+ influx in P2X7-induced ROS formation, ATP-induced ROS formation was compared
in MEL cells in the absence or presence the Ca2+ chelator EGTA. ATP induced significant
ROS formation in MEL cells in either the absence or presence of 100 µM EGTA compared to
similarly treated cells incubated in the absence of ATP (Fig. 3B). Moreover, ATP-induced
ethidium+ uptake was similar in MEL cells in either the absence or presence of EGTA (Fig.
3B) indicating that neither EGTA nor nominal amounts of extracellular Ca2+ had a direct
effect on P2X7-induced pore formation.
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Next, the potential role of intracellular Ca2+ increase in P2X7-induced ROS formation in
MEL cells was examined by comparing ATP-induced ROS formation in MEL cells
pre-incubated in the presence of DMSO or the intracellular Ca2+ chelator BAPTA-AM. ATP
induced significant ROS formation in MEL cells in either the presence of DMSO or 10 µM
BAPTA-AM compared to similarly treated cells incubated in the absence of ATP (Fig. 3C).
Moreover, ATP-induced ethidium+ uptake was similar in MEL cells in either the presence of
DMSO or BAPTA-AM (Fig. 3C) indicating that neither BAPTA-AM nor intracellular Ca2+
increase had a direct effect on P2X7-induced pore formation.
Since the current study predominately assessed P2X7-induced ROS formation in MEL
cells in NaCl medium, which may contain nominal amounts of Mg2+, the possibility remained
that this process was dependent on Mg2+ efflux. Therefore, ATP-induced ROS formation was
compared in cells in the absence or presence of 1 mM Mg2+, a concentration similar to that of
free intracellular Mg2+. ATP induced significant ROS formation in MEL cells in either the
absence or presence of Mg2+ compared to similarly treated cells incubated in the absence of
ATP (Fig. 3D). As above for Ca2+ (Fig. 3A), ATP-induced ROS formation was significantly
lower in the presence of Mg2+ compared to ATP-induced ROS formation in the absence of
Mg2+ (Fig. 3D). This result paralleled observations with ATP-induced ethidium+ uptake, with
ATP-induced ethidium+ uptake significantly lower in the presence of Mg2+ compared to
ATP-induced ethidium+ uptake in the absence of Mg2+ (Fig. 3D).
Both ROS formation and K+ efflux are involved in P2X7-induced interleukin-1β release
from monocytes, although it remains to be determined if these upstream processes are linked
[32]. Therefore, to determine if P2X7-induced ROS formation in MEL cells is dependent on
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K+ efflux, ATP-induced ROS formation was compared in cells in NaCl medium and KCl
medium, which prevents the loss of intracellular K+. The amount of ATP-induced ROS
formation in MEL cells in KCl medium was similar to ROS formation in cells in NaCl
medium (Fig. 3E). To determine if the inability of high extracellular K+ to impair
ATP-induced ROS formation was not due to altered P2X7 function in KCl medium,
ATP-induced ethidium+ uptake was assessed in cells in both media. ATP-induced ethidium+
uptake was similar in MEL cells incubated in either medium (Fig. 3E).
The above results with KCl medium (Fig. 3E) indirectly exclude a role for Na+ influx in
P2X7-induced ROS formation in MEL cells. It is well known however that high
concentrations of extracellular K+ will depolarise cells and interfere with various transport
systems. Therefore, ATP-induced ROS formation was compared in cells in NaCl medium and
NMDG Cl medium, which is nominally free of Na+. Both media were nominally free of Ca2+
and Mg2+. In contrast to observations with KCl medium above (Fig. 3E), ATP-induced ROS
formation was impaired by 88 ± 1% in MEL cells in NMDG Cl medium compared to cells in
NaCl medium (Fig. 3F). To determine if this inhibition was due to impaired P2X7 function in
NMDG Cl medium, ATP-induced ethidium+ uptake was assessed in cells in both media. In
contrast to ROS formation, ATP-induced ethidium+ uptake was approximately two-fold
greater in MEL cells incubated in NMDG Cl medium compared to cells in NaCl medium (Fig.
3F).

p38 MAPK and caspase activation, but not ROS formation, mediates P2X7-induced apoptosis
of MEL cells Our group previously demonstrated that P2X7 activation induces apoptosis of
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MEL cells [23], however the intracellular signalling pathways involved were not determined.
ROS formation, as well as the p38 MAPK and caspase pathways are involved in
P2X7-induced apoptosis of RAW264.7 macrophages [10]. Therefore, the roles of these
pathways in P2X7-induced MEL cell apoptosis were examined. First, cells were
pre-incubated in the absence or presence of NAC before incubation in the absence or
presence of ATP. As previously observed [23], incubation of MEL cells with 1 mM ATP
induced a significant increase in the percentage of Annexin-V+/7AAD− (early apoptotic) and
Annexin-V+ /7AAD+ (late apoptotic) cells (Fig. 4A). Pre-incubation of MEL cells with 10
mM NAC failed to impair ATP-induced early or late apoptosis (Fig. 4A). Moreover,
incubation of MEL cells in complete culture medium with 1 mM ATP (as used in the
apoptosis assay) did not induce significant ROS formation despite 1 mM ATP causing
significant ROS formation in MEL cells in NaCl medium (nominally free of Ca2+ and Mg2+)
(Fig. 4B).
Next, cells were pre-incubated in the presence of DMSO or the p38 MAPK inhibitors
SB202190 or SB203580 before incubation in the absence or presence of ATP. Again ATP
induced a significant increase in early and late apoptotic cells (Fig. 4C). Pre-incubation of
MEL cells with 20 µM SB202190 significantly impaired ATP-induced early and late
apoptosis by 56 ± 5% and 56 ± 9%, respectively (Fig. 4C). Similarly, pre-incubation of MEL
cells with 20 µM SB203580 impaired the amount of ATP-induced early and late apoptosis by
48 ± 17% and 52 ± 6%, respectively (Fig. 4C).
Next, cells were pre-incubated in the presence of DMSO, or the broad-spectrum caspase
inhibitor Z-VAD-FMK before incubation in the absence or presence of ATP. Again ATP
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induced a significant increase in early and late apoptotic cells (Fig. 4D). Pre-incubation of
MEL cells with 20 µM Z-VAD-FMK significantly impaired the amount of ATP-induced late
apoptotic cells by 36 ± 2% (Fig. 4D). In contrast, pre-incubation of cells with Z-VAD-FMK
failed to impair the amount of early apoptotic cells induced by ATP (Fig. 4D).
p38 MAPK and caspase inhibitors have been reported to impair P2X7-induced pore
formation [33, 34]. To exclude the possibility that the above compounds impaired
P2X7-induced apoptosis of MEL cells by directly inhibiting P2X7, cells were pre-incubated
in the presence of DMSO, SB202190, SB203580 or Z-VAD-FMK (as above), and the
P2X7-induced ethidium+ uptake assessed. ATP induced significant ethidium+ uptake into
MEL cells compared to cells incubated in the absence of ATP (Fig. 4E). Pre-incubation of
MEL cells with any of the compounds failed to alter the amount of ATP-induced ethidium+
uptake (Fig. 4E). Collectively, these results indicate that p38 MAPK and caspase activation,
but not ROS formation, are involved in P2X7-induced apoptosis of MEL cells.

P2X7 activation induces p38 MAPK and caspase activation in MEL cells To support the role
of p38 MAPK activation in the P2X7-induced apoptosis of MEL cells, ATP-induced p38
MAPK phosphorylation was examined by immunoblotting. Immunoblotting with an
anti-phospho-p38 MAPK antibody revealed that incubation of cells with ATP for 5 min
induced greater amounts of p38 MAPK activation compared to cells incubated in the absence
of ATP (Fig. 5A). Moreover, pre-incubation of cells with the P2X7 antagonist A-438079 (10
µM) impaired the amount ATP-induced p38 activation compared to ATP alone (Fig. 5A).
To support the role of caspase activation in the P2X7-induced apoptosis of MEL cells,
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ATP-induced caspase activity was examined using a FITC-conjugated caspase substrate and
flow cytometry. MEL cells were incubated in the absence or presence of ATP for 6 h, and
then for a further 1 h with FITC-VAD-FMK and the percentage of FITC+/7AAD+ cells
(caspase activation) measured by flow cytometry. Incubation of cells with ATP resulted in a
2.6-fold increase in the relative percentage of cells with activated caspases compared to cells
incubated in the absence of ATP (Fig. 5B). Pre-incubation of cells with 10 µM A-438079
impaired the amount ATP-induced caspase activation by 95 ± 9% compared to cells
incubated with ATP alone (Fig. 5B). Collectively, these results indicate that P2X7 activation
stimulates p38 MAPK and caspases, and indirectly supports a role for these enzymes in the
P2X7-induced apoptosis of MEL cells.

Discussion

The current study demonstrates that P2X7 activation results in the formation of ROS in MEL
cells, an erythroid cell line. P2X7-induced ROS formation has been previously observed in
myeloid cells [6-12, 35], glomerular mesangial cells [36] and submandibular gland cells [30,
31], but to the best of our knowledge the current study is the first to demonstrate that P2X7
activation causes ROS formation in erythroid cells. It will be of future importance to
determine if P2X7 induces ROS formation in primary erythroid cells. Moreover, it will be
important to identify the intracellular source of ROS formation downstream of P2X7
activation in erythroid cells. In the current study, use of apocynin, rotenone, allopurinol and
L-NAME, which impair NADPH oxidase, mitochondrial complex I, xanthine oxidase and
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nitric oxide synthase, respectively, failed to identify the intracellular source of P2X7-induced
ROS formation in MEL cells; however the mitochondrial respiratory chain cannot be
excluded as a source. Although rotenone is commonly used as an inhibitor of mitochondrial
ROS formation, it has been widely reported to also induce mitochondrial ROS formation [37].
Consistent with the latter, rotenone repeatedly increased basal ROS formation in MEL cells,
making it difficult to ascertain if mitochondria were the source of P2X7-induced ROS
formation. Moreover, DPI can impair mitochondrial ROS formation, as well as NADPH
oxidase ROS formation [38], supporting a possible role for mitochondria in P2X7-induced
ROS formation. The failure of apocynin to impair P2X7-induced ROS formation excludes a
role for NADPH oxidase in this process; however further studies using gene knockdown
approaches are required to support this conclusion. Nevertheless based on the current results,
the mitochondrial respiratory chain or enzyme systems other than those examined in the
current study remain the most likely sources of P2X7-induced ROS formation in erythroid
cells.
The physiological role of P2X7-induced ROS formation in erythroid cells remains to be
established. Accumulating evidence suggests that ROS are involved in cell homeostasis,
proliferation, differentiation and death [39, 40]. Specifically in relation to erythroid cells, low
amounts of ROS are involved in the differentiation of erythroid progenitors, through
interactions with FoxO3 and other transcription factors [41]. Whereas, excess amounts of
ROS may shorten the life-span of mature erythroid cells [41]. In the current study however,
the presence of the ROS scavenger NAC failed to impair P2X7-induced apoptosis of MEL
cells, suggesting that P2X7-induced ROS formation is more likely to be involved in
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signalling events related to erythroid cell homeostasis, proliferation or differentiation rather
than erythroid cell death. An alternative, but not mutually exclusive, concept is that
P2X7-induced ROS formation may result in phosphatidylserine exposure (in the absence of
immediate cell death) and the subsequent removal of erythroid precursors from the
circulation in certain disease states such as thalassaemia. In this regard, thalassaemic
DNA-containing reticulocytes and erythrocytes have a higher content of ROS and exposed
phosphatidylserine compared to DNA-free counterparts, leading the authors to postulate that
oxidative stress-induced phosphatidylserine exposure is involved in the clearance of these
cells from the circulation [42].
The current study demonstrates that Na+ influx but not K+ efflux may have a role in
P2X7-induced ROS formation in MEL cells. NMDG Cl medium, which is nominally free of
Na+, almost completely impaired P2X7-induced ROS formation, however KCl medium,
which is also nominally free of Na+, did not. These conflicting results may be explained by at
least two, but not mutually exclusive, possibilities. First, since P2X7 activation can induce
NMDG+ uptake [43], the possibility remains that P2X7-induced ROS formation is impaired
by increased intracellular NMDG+ rather than through the absence of Na+ influx. Second,
since high concentrations of extracellular K+ can depolarise cells and interfere with various
transport systems, the possibility remains that under these (KCl medium) but not other
conditions (NaCl medium) that Na+ influx is not essential for P2X7-induced ROS formation.
Reports for a role for Na+ influx in P2X7-induced signalling events are few, however others
have shown that Na+ influx is involved in P2X7-induced rapid exposure of
phosphatidylserine in murine thymocytes [44] and P2X7-induced mitochondrial membrane
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depolarisation in rat submandibular glands [45]. Thus, the current study may offer another
example of the importance of Na+ influx in a P2X7-induced signalling event. In contrast, this
study indicates that K+ efflux is not essential for P2X7-induced ROS formation in MEL cells.
Both ROS formation and K+ efflux are involved in P2X7-induced interleukin-1β from
monocytes, although it remains unknown if these upstream processes are linked [32]. The
absence of a role for K+ efflux in P2X7-induced ROS formation in MEL cells suggests that
K+ efflux and ROS formation may be involved in distinct pathways in monocyte
interleukin-1β release downstream of P2X7 activation.
The current study also demonstrates that Ca2+ influx or Mg+ efflux, or an increase in
intracellular Ca2+ is not essential for P2X7-induced ROS formation in MEL cells. Others
have shown that P2X7-induced ROS formation is dependent on Ca2+ influx in rat, but not
murine, submandibular gland cells [30, 31]. Thus, the current study with a murine erythroid
cell line parallel those of murine submandibular gland cells. Of note however, 1 mM
extracellular Ca2+ or Mg2+, but not nominal concentrations of extracellular Ca2+ (as observed
with the use of EGTA), impaired both P2X7-induced ROS formation and pore formation in
MEL cells despite the presence of equivalent ATP4- concentrations. This suggests that mM
(or perhaps µM) concentrations of extracellular Ca2+ and Mg2+ may act as allosteric inhibitors
of murine P2X7 as originally observed for rat P2X7 [46], and established by more recent
studies of rat P2X7 [28, 29]. The current study also demonstrates that an increase in
intracellular Ca2+ is not essential for P2X7-induced ROS formation (and pore formation) in
MEL cells. To the best of our knowledge the potential role of intracellular Ca2+ on
P2X7-induced ROS formation in any cell type has not been reported, although others have
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excluded a role for an increase in intracellular Ca2+ in ATP-induced organic cation uptake
into RAW264.7 macrophages and HEK-293 cells transfected with rat P2X7 [47].
The current study confirms that P2X7 activation induces apoptosis of MEL cells, and
demonstrates for the first time that this process involves activation of p38 MAPK and
caspases, but not ROS formation. The involvement of p38 MAPK and caspase activation in
P2X7-induced MEL cell apoptosis parallels observations with P2X7-induced apoptosis of
RAW264.7 cells [10]. In contrast, this previous study also demonstrated a role for ROS
formation in RAW264.7 cell apoptosis, which was not required for MEL cell apoptosis in the
current study. This difference was not due to impaired scavenger action of NAC, as this
compound impaired P2X7-induced ROS formation in MEL cells. Collectively, the above
indicates that p38 MAPK and caspase activation, and ROS formation are independent
processes downstream of P2X7 activation in MEL cells. Although the current study
demonstrated that caspase activation mediates the P2X7-induced apoptosis of MEL cells, the
identity of the caspases involved remains unknown. Others have shown that high
pressure-induced apoptosis of MEL cells involves both the extrinsic and intrinsic pathways
mediated by caspase-8 and caspase-9, respectively, as well as the downstream activation of
caspase-3 [48, 49]. Thus, it is likely that either or both caspase-8 and caspase-9, as well as
caspase-3 are involved in P2X7-induced MEL cell apoptosis.
The physiological role of P2X7-induced apoptosis of erythroid cells, as well as other cell
types remains poorly defined. Studies of P2X7-deficient mice suggest that the P2X7 is not
involved in regulating cell numbers under normal, physiological conditions [50, 51], except
in bone homeostasis [52] and the peripheral T cell compartment [53]. Nevertheless
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P2X7-induced apoptosis remains a well-described event [2, 3]. Therefore, it is likely that
P2X7-induced apoptosis may play a role in removing damaged erythroid cells to prevent the
development of anaemia or leukaemia [54], or to promote their rapid clearance from the
circulation to prevent autoimmunity [55]. Alternatively, errant ATP release and subsequent
P2X7-induced apoptosis of erythroid progenitors may be associated with the premature loss
of these cells to cause anaemia [54]. This may be particular relevant to chemotherapy, which
can cause the release of ATP from cells [56] and induce cytotoxicity in immature erythroid
progenitors to cause anaemia in cancer patients [57].
Finally, the current study demonstrates that neither the ROS scavenger (NAC) nor any of
the ROS inhibitors (DPI, apocynin, rotenone, allopurinol and L-NAME) had a direct effect on
P2X7 itself. The inability of these compounds to impair P2X7-induced pore formation in
MEL cells is consistent with similar findings in murine J774 cells and primary murine
macrophages [11]. Thus, these observations validate the current and future use of these
compounds to study ROS formation downstream of P2X7 activation, and indicate that ROS
formation does not modulate P2X7-induced pore formation. In contrast, P2X7 in some cell
types or studies can be directly impaired by a number of enzyme inhibitors [33, 34, 58-60].
Of relevance to the current study, the p38 MAPK inhibitors SB202190 or SB203580 can
impair P2X7-induced pore formation in human THP-1 myeloid cells, murine 2BH4 thymic
epithelial cells and primary murine macrophages [33, 34]. Although others have
demonstrated that these compounds impair ATP-induced pore formation mediated by human,
but not rat or murine, recombinant P2X7 [61]. This latter finding is consistent with the
absence of an inhibitory effect of SB202190 or SB203580 on P2X7-induced pore formation
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in MEL cells. The caspase-1 and caspase-3 inhibitors YVAD and DEVD, respectively have
also been shown to impair P2X7-induced pore formation in THP-1 cells [33]. However, the
broad-spectrum caspase inhibitor Z-VAD-FMK failed to impair P2X7-induced pore
formation in MEL cells.
In conclusion, these findings indicate that P2X7 activation induces ROS formation in
MEL cells and that this process may be involved in events downstream of P2X7 activation,
other than apoptosis, in erythroid cells. This study highlights the potential role of P2X7
activation in intracellular signalling pathways or oxidative stress in erythroid cells.
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Figure legends

Fig. 1 P2X7 activation induces ROS formation in MEL cells. H2DCFDA-loaded MEL cells
in (A-D) NaCl medium or (E) NaCl medium (containing 2 mM Ca2+ and 1 mM Mg2+) were
incubated at 37°C in the absence (Basal) or presence of (A) 1 mM ATP for up to 30 min, (B)
varying ATP concentrations for 15 min, (C) 1 mM ATP, UTP or ADP, or 200 µM BzATP for
15 min, (D) 10 µM A-438079 for 15 min, and then in the absence or presence of 1 mM ATP
for 15 min, or (E) 1, 2 or 3 mM ATP for 15 min. (A-E) Incubations were stopped by addition
of MgCl2 medium and centrifugation, and the mean fluorescence intensity (MFI) of DCF
(ROS formation) was determined by flow cytometry. ROS formation is expressed as (A and
C-E) MFI or (B) percentage of maximum response compared to 2 mM ATP. Results are
mean ± SD (A and C-E, n = 3; B, n = 6); where the SD is not visible, SD is ≤ 2.6; *P < 0.05,
**P < 0.01 compared to corresponding Basal; ††P < 0.01 compared to ATP alone (C and D,
ANOVA; E, Student’s t-test).

Fig. 2 P2X7-induced ROS formation in MEL cells is impaired by NAC and DPI.
H2DCFDA-loaded MEL cells (left panels) or MEL cells (right panels) in NaCl medium were
pre-incubated at 37°C in the (A, F) absence (Control), or presence of (A) 10 mM NAC for 30
min or (F) 1 mM L-NAME for 60 min, or in the presence of (B) DMSO or 20 µM DPI for 30
mins, (C) DMSO or 100 µM apocynin for 60 mins, (D) DMSO or 5 µM rotenone for 60 mins,
or (E) NaOH or 100 µM allopurinol for 30 mins. (A-F) Cells were then incubated in the
absence (Basal) or presence of 1 mM ATP at 37°C for 15 min; 25 µM ethidium+ was also
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present (right panels). Incubations were stopped by addition of MgCl2 medium and
centrifugation, and the mean fluorescence intensity (MFI) of DCF (ROS formation; left
panels) or ethidium+ uptake (pore formation; right panels) analysed by flow cytometry.
Results are mean ± SD (n = 3); *P < 0.05, **P < 0.01 compared to corresponding Basal; ††P
< 0.01 compared to ATP without NAC or antagonist; ‡‡P < 0.01 compared to Basal control.

Fig. 3 P2X7-induced ROS formation is impaired in MEL cells in NaCl medium containing
Ca2+ or Mg2+, or in NMDG Cl medium. H2DCFDA-loaded MEL cells (left panels) or MEL
cells (right panels) in (A, B and D) NaCl medium in the absence (Control) or presence of (A)
1 mM Ca2+, (B) 100 µM EGTA or (D) 1 mM Mg2+, (C) NaCl medium in the presence of
DMSO or 10 µM BAPTA-AM (pre-incubated at 37°C for 30 min), (E) NaCl or KCl medium,
or (F) NaCl or NMDG Cl medium were incubated in the absence (Basal) or presence of 415
µM ATP4- (1, 1.54 or 1.74 mM ATP as explained in Materials and methods) at 37°C for 15
min; 25 µM ethidium+ was also present (right panels). (A-F) Incubations were stopped by
addition of MgCl2 medium and centrifugation, and the mean fluorescence intensity (MFI) of
DCF (ROS formation; left panels) or ethidium+ uptake (pore formation; right panels)
analysed by flow cytometry. Results are mean ± SD (n = 3); *P < 0.05, **P < 0.01 compared
to corresponding Basal; †P < 0.05, ††P < 0.01 compared to ATP alone; ‡‡P < 0.01 compared
to Basal control.

Fig. 4 p38 MAPK and caspase activation, but not ROS formation, mediates P2X7-induced
apoptosis in MEL cells. (A, C and D) MEL cells in complete culture medium were
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pre-incubated at 37°C for 30 min (A) in the absence (Control) or presence of 10 mM NAC, in
the presence of (C) DMSO, 20 µM SB202190 or 20 µM SB203580, or (D) DMSO or 20 µM
Z-VAD-FMK. Cells were then incubated in the absence (Basal) or presence of 1 mM ATP at
37°C for 24 h. Cells were harvested, and labelled with Annexin-V-FLUOS and 7AAD, and
the percentage of Annexin-V+/7AAD− (early apoptotic; left panels) or Annexin-V+/7AAD+
(late apoptotic; right panels) cells analysed by flow cytometry. (B) H2DCFDA-loaded MEL
cells in NaCl medium or complete culture medium (CC) were incubated in the absence (Basal)
or presence of 1 mM ATP at 37°C for 15 min. Incubations were stopped by addition of
MgCl2 medium and centrifugation, and the mean fluorescence intensity (MFI) of DCF (ROS
formation) was determined by flow cytometry. (E) MEL cells in NaCl medium were
pre-incubated at 37°C for 30 min in the presence of DMSO or 20 µM SB202190 (left panel),
DMSO or 20 µM SB203580 (centre panel), or DMSO or 20 µM Z-VAD-FMK (right panel).
Ethidium+ (25 µM) was added and cells were incubated in the absence (Basal) or presence of
1 mM ATP at 37°C for 15 min. Incubations were stopped by addition of MgCl2 medium and
centrifugation, and the mean fluorescence intensity (MFI) of ethidium+ uptake (pore
formation) analysed by flow cytometry. (A-E) Results are mean ± SD (n = 3); *P < 0.05, **P
< 0.01 compared to corresponding Basal; †P < 0.05, ††P < 0.01 compared to ATP alone.

Fig. 5 P2X7 activation induces p38 MAPK and caspase activation in MEL cells. (A) MEL
cells in complete culture medium were pre-incubated in the absence or presence of 10 µM
A-438079 at 37°C for 15 min, and then in the absence or presence of 1 mM ATP at 37°C for
5 min. Whole lysates of MEL cells were then separated by SDS-PAGE, transferred to
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nitrocellulose membrane and probed with (top panel) anti-phospho-p38 (p-p38) and (bottom
panel) anti-p38 (p38) antibodies. (B) MEL cells in complete culture medium were
pre-incubated in the absence (Control) or presence of 10 µM A-438079 at 37°C for 15 min,
and then in the absence (Basal) or presence of 1 mM ATP at 37°C for 6 h. Cells were then
incubated with FITC-VAD-FMK at 37°C for 1 h and 7AAD for the final 5 min, and the
percentage of FITC+/7AAD+ (caspase activated) cells analysed by flow cytometry. Results
are mean ± SD (n = 3); **P < 0.01 compared to corresponding Basal; ††P < 0.01 compared to
ATP alone.

	
  

30	
  

